News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
587,841 Results
Type
Article (47416)
Company Profile (190)
Press Release (540235)
Section
Business (166325)
Career Advice (2570)
Deals (30322)
Drug Delivery (98)
Drug Development (76210)
Employer Resources (153)
FDA (13965)
Job Trends (13271)
News (292760)
Policy (28538)
Tag
Academia (2595)
Alliances (42590)
Alzheimer's disease (1288)
Approvals (13894)
Artificial intelligence (146)
Bankruptcy (316)
Best Places to Work (10437)
Biotechnology (153)
Breast cancer (178)
Cancer (1304)
Cardiovascular disease (115)
Career advice (2149)
CAR-T (94)
Cell therapy (283)
Clinical research (60771)
Collaboration (429)
Compensation (160)
COVID-19 (2515)
C-suite (117)
Data (1339)
Diabetes (160)
Diagnostics (5697)
Earnings (58309)
Employer resources (139)
Events (85138)
Executive appointments (366)
FDA (14562)
Funding (400)
Gene therapy (200)
GLP-1 (606)
Government (4150)
Healthcare (16440)
Infectious disease (2608)
Inflammatory bowel disease (113)
Interviews (526)
IPO (13486)
Job creations (3206)
Job search strategy (1784)
Layoffs (409)
Legal (6250)
Lung cancer (197)
Manufacturing (187)
Medical device (10705)
Medtech (10709)
Mergers & acquisitions (16955)
Metabolic disorders (438)
Neuroscience (1619)
NextGen Class of 2024 (5813)
Non-profit (4060)
Northern California (1478)
Obesity (245)
Opinion (221)
Patents (115)
People (53637)
Phase I (18881)
Phase II (26766)
Phase III (20177)
Pipeline (502)
Postmarket research (2414)
Preclinical (7837)
Radiopharmaceuticals (229)
Rare diseases (254)
Real estate (5029)
Regulatory (19486)
Research institute (2233)
Resumes & cover letters (383)
Southern California (1323)
Startups (3278)
United States (13136)
Vaccines (563)
Weight loss (184)
Date
Last 7 days (648)
Last 30 days (2332)
Last 365 days (32697)
2024 (31966)
2023 (36443)
2022 (47172)
2021 (50775)
2020 (48803)
2019 (41817)
2018 (31773)
2017 (29398)
2016 (28146)
2015 (32738)
2014 (26661)
2013 (22703)
2012 (21952)
2011 (22802)
2010 (20426)
Location
Africa (811)
Arizona (120)
Asia (36350)
Australia (7327)
California (3329)
Canada (1322)
China (281)
Colorado (141)
Connecticut (149)
Europe (85568)
Florida (470)
Georgia (106)
Illinois (346)
Indiana (202)
Maryland (569)
Massachusetts (2514)
Michigan (158)
Minnesota (245)
New Jersey (962)
New York (947)
North Carolina (670)
Northern California (1478)
Ohio (124)
Pennsylvania (760)
South America (1115)
Southern California (1323)
Texas (481)
Utah (104)
Washington State (371)
587,841 Results for "vernalis plc formerly known as british biotech plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Trinity Biotech plc to Announce Q1 2024 Financial Results
Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report financial results for the first quarter 2024 on Thursday, May 23, 2024 at 8:30 AM ET.
May 21, 2024
·
1 min read
Press Releases
Angle PLC Announces HER2 Presentation at SABCS
December 13, 2024
·
5 min read
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
Trinity Biotech plc will report financial results for the fourth quarter and fiscal year 2023 on Thursday, April 4, 2024 at 8:00 AM ET.
March 28, 2024
·
1 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
·
3 min read
Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
ANGLE plc is pleased to announce its participation at the 2024 Annual Congress of the European Association for Cancer Research being held in Rotterdam, Netherlands from 10 to 13 June 2024.
June 11, 2024
·
5 min read
Press Releases
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
November 15, 2024
·
5 min read
Press Releases
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
November 15, 2024
·
5 min read
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
Trinity Biotech Plc. announced that it has finalized the effective date of its ratio change of its American depositary shares from one ADS representing four Class A ordinary shares to one ADS representing twenty Class A ordinary shares.
February 15, 2024
·
3 min read
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Trinity Biotech Plc. announced that it plans to change the ratio of the American depositary shares representing its Class A ordinary shares from one ADS representing four Class A ordinary share to one ADS representing twenty Class A ordinary shares.
February 13, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 6, 2024
·
3 min read
1 of 58,785
Next
